Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_assertion type Assertion NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_head.
- NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_assertion description "[These results contribute to a deeper understanding of the properties of transgenic lymphocytes used to treat human malignancies and may provide a rationale for the development of combination therapies as a method to improve ACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_provenance.
- NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_assertion evidence source_evidence_literature NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_provenance.
- NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_assertion SIO_000772 23861247 NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_provenance.
- NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_assertion wasDerivedFrom befree-20150227 NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_provenance.
- NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_assertion wasGeneratedBy ECO_0000203 NP221886.RAbGbyREJR39TCkM4v5R17yhALpwup_xAUXz8Ra923ARQ130_provenance.